Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

  1. Inlyta


Axitinib is used together with other medicines (eg, avelumab, pembrolizumab) as first-line treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. This medicine is also used alone to treat advanced kidney cancer in patients who have received at least one cancer treatment (cancer medicine given by mouth or injection) but did not work well.

Axitinib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed.

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Tablet